2Marks K,Barton SP,Shuttleworth D,et al.Assessment of disease progress in psoriasis[J].Arch Dermatol,1989,125(2):233-240.
3陆德铭.中医外科学[M].上海:上海科学技术出版社,2000:89.
4Ehmann CW,Voorhees JJ.International studies of the efficacy of etretinate in the treatment of psoriasis[J].J Am Acad Dermatol,1982,6(4pt 2 Suppl):692-696.
1van de Kerkhof PC. The Psoriasis Area and Severity Index and altermative approaches for the assessment of severity: persisting areas of confusion. Br J Dermatol, 1997,137(4):661-662.
2Harari M, Shani J, Hristakieva E, et al. Clinical evaluation of a more repid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead-Sea, Int J Dermatol, 2000,39(12) :913-918.
3Exum ML, Rapp SR, Feldman SR, et al. Measuring severity of psoriasis: methodological issues. J Dermatol Treat, 1996,7:119-124.
4Marks R. Measurement of the response to treatment in psoriasis. J Dermatol Treat, 1996,7(Suppl 1):57.
5Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol. 1991.124(5):555-570.
6Faust HB. Gonin R. Chuang TY. et al. Reliability testing of the dermatology index of disease severity (DIDS). An index for staging the severity of cutaneous inflammatory disease. Arch Dermatol, 1997,133(11):1443-1448.
7Savolainen L, Kontinen J, Roning J, et al. Application of machine vision to assess involved surface in patients with psoriasis. Br J Dermatol, 1997,137(3):395-400.
8Ashcroft DM, Wan Po AL, Williams HC, et al. Clinical mesasures of disease severity and cutcome in psoriasis: a critical appraisal of their quality. Br J Dermatol, 1999,141(2):185-191.
9Snellman E, Maljanen T, Aromaa A, et al. Effect of heliotherapy on the cost of psoriasis. Br J Dermatol, 1998,138(2):288-292.
10Feldman SR, Fleischer AB Jr, Reboussin DM, et al. The self-administratered psoriasis area and severity index is valid and reliable. J Invest Dermatol, 1996,106(1):183-186.
